MIR4682

Across TCGA pan-cancer cohorts, MIR4682 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR4682 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR4682 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4682 expression acts as an unfavorable survival marker, although some lineages such as BRCA and STAD show a favorable association.

LUAD, THCA, and ESCA are the cancer types where MIR4682 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.464	0.817	.001	69	view →
THCA	DFS	Tertile	All	0.485	0.854	<.001	54	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
CESC	DFS	Tertile	IV	0.121	0.548	.002	36	view →
BRCA	DFS	Tertile	All	0.938	0.884	.002	35	view →
LIHC	OS	Tertile	All	0.616	0.801	.001	33	view →
DLBC	DFS	Tertile	All	0.309	0.765	.016	27	view →
STAD	DFS	Quartile	IV	0.630	0.255	.022	24	view →
TGCT	DFS	Tertile	All	0.502	0.711	.020	24	view →
KIRC	DFS	Tertile	IV	0.184	0.382	.015	22	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
BLCA	OS	Tertile	II,III,IV	0.848	0.691	.015	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR4682–LUAD (DFS)

Open the LUAD breakdown →